GB0723747D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0723747D0 GB0723747D0 GB0723747A GB0723747A GB0723747D0 GB 0723747 D0 GB0723747 D0 GB 0723747D0 GB 0723747 A GB0723747 A GB 0723747A GB 0723747 A GB0723747 A GB 0723747A GB 0723747 D0 GB0723747 D0 GB 0723747D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0723747A GB0723747D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
| PCT/GB2008/004000 WO2009071888A1 (fr) | 2007-12-04 | 2008-12-03 | Pyrrolothiazoles comme inhibiteurs de la pi3 kinase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0723747A GB0723747D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0723747D0 true GB0723747D0 (en) | 2008-12-31 |
Family
ID=40230536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0723747A Ceased GB0723747D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0723747D0 (fr) |
| WO (1) | WO2009071888A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI378933B (en) | 2008-10-14 | 2012-12-11 | Daiichi Sankyo Co Ltd | Morpholinopurine derivatives |
| WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| FR2969611B1 (fr) * | 2010-12-28 | 2013-02-08 | Sanofi Aventis | Nouveaux derives de thiazoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb) |
| WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
| WO2013045413A1 (fr) | 2011-09-27 | 2013-04-04 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
| WO2014068070A1 (fr) | 2012-10-31 | 2014-05-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés pour prévenir le syndrome des antiphospholipides (sapl) |
| WO2016059220A1 (fr) | 2014-10-16 | 2016-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Agents d'activation du tcr à utiliser dans le traitement de la lla-t |
| FR3033499A1 (fr) | 2015-03-11 | 2016-09-16 | Centre Leon-Berard | Composition pour le traitement des tumeurs neuroendocrines pancreatiques |
| WO2017205536A2 (fr) * | 2016-05-24 | 2017-11-30 | Genentech, Inc. | Composés thérapeutiques et leurs utilisations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0508471D0 (en) * | 2005-04-26 | 2005-06-01 | Celltech R&D Ltd | Therapeutic agents |
-
2007
- 2007-12-04 GB GB0723747A patent/GB0723747D0/en not_active Ceased
-
2008
- 2008-12-03 WO PCT/GB2008/004000 patent/WO2009071888A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009071888A1 (fr) | 2009-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0811304D0 (en) | Therapeutic agents | |
| GB0609492D0 (en) | Therapeutic agents | |
| IL201235A0 (en) | Therapeutic agents | |
| GB0608928D0 (en) | Therapeutic agents | |
| GB0811643D0 (en) | New therapeutic agents | |
| GB0601962D0 (en) | Therapeutic agents | |
| GB0819593D0 (en) | Therapeutic agents | |
| GB0723747D0 (en) | Therapeutic agents | |
| GB0821693D0 (en) | Therapeutic agents | |
| GB0801081D0 (en) | Therapeutic agents | |
| GB0801080D0 (en) | Therapeutic agents | |
| GB0812309D0 (en) | Therapeutic agents | |
| GB0616214D0 (en) | Therapeutic Agents | |
| GB0724340D0 (en) | Novel Therapeutic Agents | |
| GB0805818D0 (en) | Therapeutic agents | |
| GB0611152D0 (en) | Therapeutic agents | |
| GB0620818D0 (en) | Therapeutic agents | |
| GB0620059D0 (en) | Therapeutic agents | |
| GB0609676D0 (en) | Therapeutic agents | |
| GB0723748D0 (en) | Therapeutic agents | |
| EP2454276A4 (fr) | Agents thérapeutiques | |
| GB0808690D0 (en) | Therapeutic use | |
| GB0811715D0 (en) | Therapeutic agents | |
| GB0622195D0 (en) | Therapeutic agents | |
| GB0716072D0 (en) | Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |